Arem Pacific Corporation
Arem Pacific Corporation (ARPC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
arpc · pe ratio · data through Jun 30, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Arem Pacific Corporation (ARPC) measures how much investors pay for each dollar of the company's trailing earnings. ARPC's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-06-30
PE Ratio History
2013 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%1345.5x
MedianQ3 · 75%5495.7x
Max
At N/A, ARPC's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Arem Pacific CorporationYou ARPC | $0M | N/A | — | -$0.00 |
 American Mobile Dental Corp. AMBD | $0M | N/A | — | -$0.00 |
 China Medicine Corporation CHME | $1M | 38.22x | — | $0.11 |
 Health Logic Interactive Inc. CHYPF | $0M | N/A | — | -$0.01 |
 CYduct Diagnostics, Inc. CYDX | $2M | N/A | — | -$0.08 |
 Endexx Corporation EDXC | $0M | N/A | — | -$0.01 |
 Epigenomics AG EPGNF | $1M | N/A | — | -$0.36 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-06-30Latest FY2023 | — | $-0.00 | — | |
2022-06-30 FY2022 | 184.71x | $0.00 | -86.3% | |
2021-06-30 FY2021 | 1345.51x | $0.00 | — | |
2020-06-30 FY2020 | — | $-0.00 | — | |
2019-06-30 FY2019 | 5495.72x | $0.00 | -88.3% | |
2016-06-30 FY2016 | — | $0.00 | — | |
2015-06-30 FY2015 | — | $-0.00 | — | |
2014-06-30 FY2014 | — | $-0.00 | — | |
2013-06-30 FY2013 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Arem Pacific Corporation (ARPC) measures how much investors pay for each dollar of the company's trailing earnings. ARPC's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Frequently asked questions
ARPC pe ratio · 6 questionsARPC's current PE ratio is N/A as of 2026-06-15, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via ARPC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Arem Pacific Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15